US STOCK
ABBV Stock Analysis
US stocks · market data · technical indicators
ABBVIE INC.
ABBVUS stocksQuote delayed 15 min
9/11 下午12:41 updated
$255.00
+4.09+1.63%
Open
$251.23
High
$255.31
Low
$249.74
Volume
439.98萬
ABBV price history
+1.67%Open
250.82
Latest
255.00
High
265.97
Low
248.78
Average
257.93
Advertisement
AI Composite Technical Analysis
BetaFormula: fundamentals (40%) + technical indicators (30%) + market sentiment (30%)
AI Score65
Score range 0–100; a higher score indicates a stronger buy signal
Market Status
HoldCurrent Price$255
Target Price$293.25
Change %+1.63%
Institutional
Moderate
Foreign Ownership
Accumulating
Market Heat
Positive
Fundamentals (US)
P/E Ratio
72.72x
ROE
--
P/B Ratio
-76.64x
Dividend Yield
2.76%
Market Insight
The score sits in neutral territory (65/100). Waiting for a clearer signal may be warranted. The target price implies roughly 15.00% upside.
This analysis is for reference only and does not constitute investment advice. Investing carries risk; educational content only.
Financial snapshot
ABBV - AbbVie Inc.
EPS
3.54USD
Forward EPS
16.28USD
P/E
72.72x
Forward P/E
15.81x
P/B
-76.64x
ROE
--
ROA
10.51%
Operating margin
40.04%
Profit margin
9.80%
Revenue growth
10.20%
Earnings growth
290.40%
Dividend yield
2.76%
Financial statements
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| Revenue | $16.99B | $15.00B | $16.62B | $15.78B | $15.42B |
| Gross profit | $12.70B | $10.78B | $12.07B | $10.47B | $11.08B |
| Operating income | $6.72B | $4.73B | $5.81B | $4.58B | $5.72B |
| Net income | $3.61B | $695.00M | $1.82B | $186.00M | $938.00M |
| Basic EPS | 2.04 | 0.39 | 1.03 | 0.11 | 0.53 |
| Diluted EPS | 2.03 | 0.39 | 1.02 | 0.10 | 0.52 |
Estimates vs actuals
Next earnings
2026-10-29
EPS estimate
3.84
Revenue estimate
$17.31B
Last surprise
+1.15%
| Date | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-10-29 | 3.84 | Not reported | — |
| 2026-07-31 | 3.61 | 3.65 | +1.15% |
| 2026-04-29 | 2.67 | 2.65 | -0.77% |
| 2026-02-04 | 2.65 | 2.71 | +2.16% |
| 2025-10-31 | 1.78 | 1.86 | +4.23% |
| 2025-07-31 | 2.91 | 2.97 | +2.14% |
| 2025-04-25 | 2.40 | 2.46 | +2.62% |
| 2025-01-31 | 2.12 | 2.16 | +1.92% |
| 2024-10-30 | 2.92 | 3.00 | +2.82% |
| 2024-07-25 | 2.66 | 2.65 | -0.39% |
| 2024-04-26 | 2.26 | 2.31 | +2.37% |
| 2024-02-02 | 2.80 | 2.79 | -0.32% |
Institutional holders
| Institution | Quarter | Value held | Portfolio weight |
|---|---|---|---|
| VANGUARD GROUP INC | 2025-12-31 | $41.3B | 0.60% |
| BlackRock Inc. | 2024-06-30 | $23.4B | 0.53% |
| STATE STREET CORP | 2026-06-30 | $20.8B | 0.62% |
| CITADEL ADVISORS LLC | 2026-06-30 | $797.6M | 0.09% |
| TWO SIGMA INVESTMENTS, LP | 2026-06-30 | $49.9M | 0.04% |
| Bridgewater Associates, LP | 2026-06-30 | $3M | 0.01% |
13F quarterly filings. Reporting periods differ by institution; value and weight reflect each institution's own latest quarter.
Analyst ratings
Mean target
$277.31
Target range
$200.00 – $328.00
Implied upside
7.72%
Strong buy
8
Buy
17
Hold
5
Sell
0
Strong sell
1
Dividends
Annual yield
2.68%
Frequency
Quarterly
Recent payouts
- 2026-07-15$1.7300
- 2026-04-15$1.7300
- 2026-01-16$1.7300
- 2025-10-15$1.6400
Advertisement